Navigation Links
Avoiding Drugs During Pregnancy

Reports suggest as many as 14 percent of pregnant women suffer from depression and up to 35 percent of women use antidepressants during pregnancy. Studies involving infants exposed to anti –depressants // in the womb have shown few ill effects, so most doctors believe these drugs can be safely prescribed for pregnant women. However, most studies have only compared major outcomes, such as physical growth and complications evident on the medical record.

In a more recent study researchers found that women who use a serotonin reuptake inhibitor (SSRI) to treat depression or other psychiatric problems during pregnancy may be putting their infants at risk for neurobehavioral problems.

Researchers studied 17 full-term newborns whose mothers had taken an SSRI during pregnancy and 17 similar infants whose mothers had not taken one of the drugs, assessing them for more subtle neurobehavioral differences. They found infants exposed to SSRIs in the womb were more likely to have had a shorter gestational age, and were also more likely to suffer from a range of neurobehavioral problems, including nervousness, startles, and sleep disturbances.

In conclusion researchers say their results call into question the conclusion that SSRI use during pregnancy has little impact on the developing fetus and infant outcome.
'"/>




Page: 1

Related medicine news :

1. Top Ten Super Food Items That Can Help In Avoiding Cancer
2. Top Ten Super Food Items That Can Help In Avoiding Cancer
3. Another Feather In The Garlic Cap: Helpful In Avoiding Breast Cancer
4. Americans Avoiding Risky Foods
5. Preventing Falls May Be Key to Avoiding Disability in Elderly
6. Tips for Avoiding Foot Fungus in Communal Bathrooms
7. eSie Touch Elasticity Imaging, and a Promise of Avoiding Breast Biopsies
8. Lean Protein Could Be Key to Obesity Drugs
9. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
10. Nasal Spray Could Take Drugs Direct to Brain.
11. Emphasis to ban Drugs ads by Doctors
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/27/2017)... Sedona, Arizona (PRWEB) , ... February 27, 2017 ... ... Premier Center for Shamanic Healing and Spiritual Awakening, is happy to announce ... reboot for mind and body, these individual customized retreats offer the winter-weary soul ...
(Date:2/27/2017)... ... 27, 2017 , ... This webinar , sponsored by ... tool to characterize particle size distributions in the field of geoscience and soil ... scientific findings. It describes methods of optimized and standardized sample collection, preparation and ...
(Date:2/27/2017)... ... 27, 2017 , ... Silicon Valley Hair Institute, a professional ... informational post on robotic hair transplantation. San Francisco residents may be confused over ... Unit Transplantation (FUT) can sound similar. Either treatment can be used to provide ...
(Date:2/26/2017)... ... February 26, 2017 , ... This is an ... world’s first to be ISO/IEC 17025:2005 INAB accredited for Der p 1 (house ... is the globally recognised standard that sets out requirements for the technical competence ...
(Date:2/26/2017)... ... February 26, 2017 , ... ODH, Inc.™ announced today it will ... the Sheraton Pentagon City Hotel in Arlington, VA. ODH’s director of medical strategy, Candace ... analytics to improve Medicaid population health management. , ODH will also have an exhibit ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... Feb. 27, 2017  A landmark study ... , MBBS, PhD, FRACS, of  Sydney Heart and ... Sydney will be published in the February 28, ... American College of Cardiology . According to the study, which ... bypass surgery technique (anOPCABG) reduced postoperative stroke ...
(Date:2/27/2017)...  International Biophysics Corporation, a global medical device manufacturer based ... 34% revenue growth in 2016 when compared to the previous ... growth was fueled by its AffloVest® sales in ... of its global sales of surgical product lines. ... enter our 25 th year in delivering high-quality, innovative ...
(Date:2/27/2017)... Md. , Feb. 27, 2017  RegeneRx ... a clinical-stage drug development company focused on tissue ... licensee for RGN-137, GtreeBNT Co., Ltd., received a ... Phase 3 clinical trial design for RGN-137 to ... wound healing gel that incorporates Thymosin beta 4 ...
Breaking Medicine Technology: